The PMHNP has diagnosed a 9-year-old boy with attention deficit hyperactivity disorder (ADHD) and is prescribing medication. As she discusses the medication with the mother, she can see the mother is becoming visibly anxious. What does the PMHNP do next?

Choice A reason: Avoiding prescribing the medication does not address the parent’s concerns and may compromise treatment. Choice B reason: Addressing the parent’s anxiety ensures informed consent, builds trust, and improves adherence to treatment. Clarifying concerns can alleviate misconceptions and provide psychoeducation about ADHD medications. Choice C reason: Continuing without addressing the observed anxiety may increase parental resistance and reduce engagement in treatment. Choice D reason: Minimizing concerns or reassuring without explanation may invalidate the parent’s feelings and reduce collaboration.